Found: 10
Select item for more details and to access through your institution.
Simultaneous stimulation of urokinase and tissue-type plasminogen activators by phorbol esters in human ovarian carcinoma cells.
- Published in:
- Journal of Cellular Physiology, 1989, v. 138, n. 1, p. 106, doi. 10.1002/jcp.1041380115
- By:
- Publication type:
- Article
Plasminogen Activators in Endometrial Physiology and Embryo Implantation: A Review.
- Published in:
- Annals of the New York Academy of Sciences, 1991, v. 622, n. 1, p. 167, doi. 10.1111/j.1749-6632.1991.tb37860.x
- By:
- Publication type:
- Article
Using Simulation with Hardware Verification for Teaching Computer Architecture.
- Published in:
- Computer Applications in Engineering Education, 1995, v. 3, n. 3, p. 173, doi. 10.1002/cae.6180030305
- By:
- Publication type:
- Article
Microtubule-Targeting Agents Eribulin and Paclitaxel Differentially Affect Neuronal Cell Bodies in Chemotherapy-Induced Peripheral Neuropathy.
- Published in:
- Neurotoxicity Research, 2017, v. 32, n. 1, p. 151, doi. 10.1007/s12640-017-9729-6
- By:
- Publication type:
- Article
Effects of Paclitaxel and Eribulin in Mouse Sciatic Nerve: A Microtubule-Based Rationale for the Differential Induction of Chemotherapy-Induced Peripheral Neuropathy.
- Published in:
- Neurotoxicity Research, 2016, v. 29, n. 2, p. 299, doi. 10.1007/s12640-015-9580-6
- By:
- Publication type:
- Article
Neuropathy-Inducing Effects of Eribulin Mesylate Versus Paclitaxel in Mice with Preexisting Neuropathy.
- Published in:
- Neurotoxicity Research, 2013, v. 24, n. 3, p. 338, doi. 10.1007/s12640-013-9394-3
- By:
- Publication type:
- Article
Synergistic Anti-Tumor Activity of EZH2 Inhibitors and Glucocorticoid Receptor Agonists in Models of Germinal Center Non-Hodgkin Lymphomas.
- Published in:
- PLoS ONE, 2014, v. 9, n. 12, p. 1, doi. 10.1371/journal.pone.0111840
- By:
- Publication type:
- Article
Effective antibody therapy induces host-protective antitumor immunity that is augmented by TLR4 agonist treatment.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 1, p. 49, doi. 10.1007/s00262-011-1090-7
- By:
- Publication type:
- Article
Systematic Analysis of Genetic and Pathway Determinants of Eribulin Sensitivity across 100 Human Cancer Cell Lines from the Cancer Cell Line Encyclopedia (CCLE).
- Published in:
- Cancers, 2022, v. 14, n. 18, p. N.PAG, doi. 10.3390/cancers14184532
- By:
- Publication type:
- Article
GDF15 Is an Eribulin Response Biomarker also Required for Survival of DTP Breast Cancer Cells.
- Published in:
- Cancers, 2022, v. 14, n. 10, p. 2562, doi. 10.3390/cancers14102562
- By:
- Publication type:
- Article